Abstract: In this talk, I will highlight the way that digital and platform mindsets have shaped the way Moderna carries out its mission to deliver on the promise of mRNA therapies to help patients. I will introduce my group, discuss our vision for data science and AI at Moderna, and highlight a recent example applying machine learning to the challenge of protein sequence design.
Bio: Andrew Giessel is the Director of Data Science and AI at Moderna, where he leads a team of data scientists applying machine learning to solve a diverse set of science, business, and engineering problems. While at Moderna, he and his team have helped the company grow from a 300 employee start-up to a commercial organization producing hundreds of millions of vaccine doses all over the world. Prior to Moderna, Andrew earned a Ph.D. and did postdoc in the Neurobiology department at Harvard Medical School. Andrew lives in the Boston area with his family.